When Cancer Immunotherapy Silences the Thyroid Twice: A Rare One-Two Endocrine Blow
A new case report describes a pembrolizumab-treated patient who developed primary hypothyroidism from immune thyroid destruction followed by rare isolated ...
A new case report describes a pembrolizumab-treated patient who developed primary hypothyroidism from immune thyroid destruction followed by rare isolated ...
A case report describes recurrent severe hypothermia emerging eight years after successful chemoradiotherapy for a suprasellar germinoma, highlighting delayed hypothalamic ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine